KUALA LUMPUR, Oct 20 (Bernama) -- Contract research organisation Fortrea has completed its acquisition of the Early Phase Services division from Worldwide Clinical Trials, in an all-cash transaction valued at approximately US$45 million. (US$1 = RM4.07)
Business : Fortrea Expands Early-Phase Trial Capacity With US$45 Mln Deal
Fortrea Expands Early-Phase Trial Capacity With US
BE Bernama 
Key takeaways
Fortrea acquired Early Phase Services for $45 million, expanding its clinical trial capacity and capabilities.
- Fortrea bought Early Phase Services from Worldwide Clinical Trials for $45 million.
- The acquisition includes a 200-bed CRU and a bioanalytical lab in Texas.
- It enhances Fortrea's early-phase trial capacity to over 570 beds globally.
Summarised automatically by AI from the original article by Bernama. AI can make mistakes, so check the original for details.
Read the full story on Bernama That's the opening of the story. The full piece is published by Bernama.
Continue reading ↗ Story details
- Published
- Section
- news
- Format
- Article
- Original
- bernama.com ↗
Topics
Related reporting
2 stories on this topic from 2 sources, oldest first.
- Bernama Business : Fortrea Expands Early-Phase Trial Capacity With US$45 Mln Deal (this story)
